BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,252,590 | -21.1% | 8,783,891 | +4.8% | 1.62% | -8.8% |
| Q2 2023 | $267,656,246 | +2.0% | 8,382,595 | -2.2% | 1.77% | -1.8% |
| Q1 2023 | $262,518,396 | -18.3% | 8,573,429 | +4.4% | 1.80% | -35.2% |
| Q4 2022 | $321,215,553 | -20.6% | 8,213,131 | -3.3% | 2.78% | -1.2% |
| Q3 2022 | $404,508,000 | +30.8% | 8,490,936 | -3.4% | 2.82% | +54.1% |
| Q2 2022 | $309,305,000 | -34.2% | 8,792,064 | +7.2% | 1.83% | -6.8% |
| Q1 2022 | $469,903,000 | -26.1% | 8,200,749 | +2.7% | 1.96% | +2.0% |
| Q4 2021 | $636,197,000 | +6.9% | 7,983,401 | +16.7% | 1.92% | +34.5% |
| Q3 2021 | $595,298,000 | -28.4% | 6,841,722 | +5.9% | 1.43% | -7.6% |
| Q2 2021 | $831,643,000 | +117.4% | 6,461,367 | +35.2% | 1.55% | +103.7% |
| Q1 2021 | $382,519,000 | +314.0% | 4,779,104 | +322.3% | 0.76% | +208.9% |
| Q4 2020 | $92,386,000 | – | 1,131,623 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
| HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
| Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
| ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
| Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
| Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
| Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.54% |
| Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |